Both our results and those obtained by Whitehall[20] show that a significant number of samples from colorectal tumor and NSCLC contain mixtures of KRAS wild-type and KRAS mutant cells, and that in many cases the percentage of mutant cells is below the threshold that can be detected by direct sequencing. This evidence concerns the gene KRAS and colorectal neoplasm.